Real-world evidence of systemic treatment practices for biliary tract cancer in Japan: Results of a database study.

These results demonstrated potential challenges of BTC in Japanese clinical practice particularly use of multiple regimens, commonly monotherapies, which are not recommended as first-line treatment, and the management of biliary infections during systemic therapy.